Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from InteliCare Holdings Limited ( (AU:ICR) ).
InteliCare Holdings Limited has lodged details with the ASX for a proposed issue of up to 16,500,000 performance rights under the security code ICRAP. The issue is structured as a placement or other type of security issue, with the proposed issue date of March 27, 2026, and is subject to the standard ASX Listing Rules and quotation application processes.
The new performance rights allocation signals a fresh round of equity-based incentives that may influence the company’s capital structure and align management or staff rewards with future performance. While specific recipients and vesting conditions are not disclosed in the filing, the move underscores InteliCare’s use of equity instruments as part of its broader funding and remuneration strategy within the competitive health-tech sector.
The most recent analyst rating on (AU:ICR) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on InteliCare Holdings Limited stock, see the AU:ICR Stock Forecast page.
More about InteliCare Holdings Limited
InteliCare Holdings Limited is an Australian-listed technology company focused on care and monitoring solutions, trading on the ASX under the code ICR. The business operates in the broader health and aged-care technology space, providing sensor-based or data-driven services designed to improve safety and support for vulnerable or remote individuals.
Average Trading Volume: 729,753
Technical Sentiment Signal: Buy
Current Market Cap: A$9.33M
Find detailed analytics on ICR stock on TipRanks’ Stock Analysis page.